Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898403786> ?p ?o ?g. }
- W2898403786 endingPage "9" @default.
- W2898403786 startingPage "1" @default.
- W2898403786 abstract "Introduction: Immune checkpoint inhibitors have considerably changed the landscape of oncology. However apart from world-acclaimed success stories limited to melanoma and lung cancer, many solid tumors failed to respond to immune checkpoint inhibitors due to limited immunogenicity, unfavorable tumor micro-environments (TME), lack of infiltrating T lymphocytes or increases in Tregs.Areas covered: Combinatorial strategies are foreseen as the future of immunotherapy and using cytotoxics or modulating agents is expected to boost the efficacy of immune checkpoint inhibitors. In this respect, nanoparticles displaying unique pharmacokinetic features such as tumor targeting properties, optimal payload delivery and long-lasting interferences with TME, are promising candidates for such combinations. This review covers the basis, expectancies, limits and pitfalls of future combination between nanoparticles and immune check point inhibitors.Expert opinion: Nanoparticles allow optimal delivery of variety of payloads in tumors while sparing healthy tissue, thus triggering immunogenic cell death. Depleting tumor stroma could further help immune cells and monoclonal antibodies to better circulate in the TME, plus immune-modulating properties of the charged cytotoxics. Finally, nanoparticles themselves present immunogenicity and antigenicity likely to boost immune response at the tumor level." @default.
- W2898403786 created "2018-11-02" @default.
- W2898403786 creator A5003169177 @default.
- W2898403786 creator A5021044017 @default.
- W2898403786 creator A5050274362 @default.
- W2898403786 creator A5063987547 @default.
- W2898403786 creator A5087626284 @default.
- W2898403786 creator A5088425379 @default.
- W2898403786 creator A5090050048 @default.
- W2898403786 date "2018-10-24" @default.
- W2898403786 modified "2023-10-18" @default.
- W2898403786 title "Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles" @default.
- W2898403786 cites W1683956275 @default.
- W2898403786 cites W1966529586 @default.
- W2898403786 cites W1977357831 @default.
- W2898403786 cites W2000755721 @default.
- W2898403786 cites W2008534009 @default.
- W2898403786 cites W2011458181 @default.
- W2898403786 cites W2017333482 @default.
- W2898403786 cites W2020451302 @default.
- W2898403786 cites W2021725662 @default.
- W2898403786 cites W2033708244 @default.
- W2898403786 cites W2035202016 @default.
- W2898403786 cites W2044835625 @default.
- W2898403786 cites W2047866259 @default.
- W2898403786 cites W2047902191 @default.
- W2898403786 cites W2049877674 @default.
- W2898403786 cites W2056227592 @default.
- W2898403786 cites W2062731441 @default.
- W2898403786 cites W2079315541 @default.
- W2898403786 cites W2083437069 @default.
- W2898403786 cites W2084657557 @default.
- W2898403786 cites W2089905323 @default.
- W2898403786 cites W2092699829 @default.
- W2898403786 cites W2096472814 @default.
- W2898403786 cites W2099352165 @default.
- W2898403786 cites W2101250684 @default.
- W2898403786 cites W2106810178 @default.
- W2898403786 cites W2107444854 @default.
- W2898403786 cites W2113657892 @default.
- W2898403786 cites W2123469465 @default.
- W2898403786 cites W2136627573 @default.
- W2898403786 cites W2144536924 @default.
- W2898403786 cites W2148707387 @default.
- W2898403786 cites W2166937531 @default.
- W2898403786 cites W2227994559 @default.
- W2898403786 cites W2228271062 @default.
- W2898403786 cites W2365348826 @default.
- W2898403786 cites W2465142962 @default.
- W2898403786 cites W2465368460 @default.
- W2898403786 cites W2469758901 @default.
- W2898403786 cites W2554479252 @default.
- W2898403786 cites W2558284519 @default.
- W2898403786 cites W2605095659 @default.
- W2898403786 cites W2609067836 @default.
- W2898403786 cites W2749105855 @default.
- W2898403786 cites W2758273859 @default.
- W2898403786 cites W2760282821 @default.
- W2898403786 cites W2761946249 @default.
- W2898403786 cites W2776126183 @default.
- W2898403786 cites W2782949806 @default.
- W2898403786 cites W2785277845 @default.
- W2898403786 cites W2789677706 @default.
- W2898403786 cites W2790273431 @default.
- W2898403786 cites W2791277913 @default.
- W2898403786 cites W2792515217 @default.
- W2898403786 cites W2793026324 @default.
- W2898403786 cites W2794616539 @default.
- W2898403786 cites W2795186863 @default.
- W2898403786 cites W2795615530 @default.
- W2898403786 cites W2800757159 @default.
- W2898403786 cites W2804357818 @default.
- W2898403786 cites W2807162252 @default.
- W2898403786 cites W2808926900 @default.
- W2898403786 cites W2836754285 @default.
- W2898403786 cites W2862652267 @default.
- W2898403786 cites W2885206115 @default.
- W2898403786 cites W2891359906 @default.
- W2898403786 doi "https://doi.org/10.1080/17425255.2018.1540588" @default.
- W2898403786 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30354685" @default.
- W2898403786 hasPublicationYear "2018" @default.
- W2898403786 type Work @default.
- W2898403786 sameAs 2898403786 @default.
- W2898403786 citedByCount "17" @default.
- W2898403786 countsByYear W28984037862019 @default.
- W2898403786 countsByYear W28984037862020 @default.
- W2898403786 countsByYear W28984037862021 @default.
- W2898403786 countsByYear W28984037862022 @default.
- W2898403786 countsByYear W28984037862023 @default.
- W2898403786 crossrefType "journal-article" @default.
- W2898403786 hasAuthorship W2898403786A5003169177 @default.
- W2898403786 hasAuthorship W2898403786A5021044017 @default.
- W2898403786 hasAuthorship W2898403786A5050274362 @default.
- W2898403786 hasAuthorship W2898403786A5063987547 @default.
- W2898403786 hasAuthorship W2898403786A5087626284 @default.
- W2898403786 hasAuthorship W2898403786A5088425379 @default.
- W2898403786 hasAuthorship W2898403786A5090050048 @default.
- W2898403786 hasBestOaLocation W28984037862 @default.